Evidence map›Paper›PMID 36677779›Full record

ArticleMolecules (Basel, Switzerland)2023

Effects of the Novel LaPLa-Enriched Medium- and Long-Chain Triacylglycerols on Body Weight, Glycolipid Metabolism, and Gut Microbiota Composition in High Fat Diet-Fed C57BL/6J Mice.

Jinyuan Shi, Qianqian Wang, Chuang Li, Mengyu Yang, Muhammad Hussain, Junhui Zhang, Fengqin Feng, Hao Zhong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jinyuan ShiCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Qianqian WangCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Chuang LiCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Mengyu YangCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Muhammad HussainCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Junhui ZhangCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Fengqin FengCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-9770-1721
Hao ZhongCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.ORCID 0000-0003-2344-861X
Zhejiang University · CNZhejiang University of Technology · CN

Funding

China Postdoctoral Science Foundation 2022M721715Zhejiang Provincial Natural Science Foundation Q23C200039
6 · The paper itself

Abstract

The roles of medium- and long-chain triacylglycerols (MLCT) on health benefits under high fat diet (HFD) conditions remain in dispute. This study was conducted to investigate the effects of novel LaPLa-rich MLCT on the glycolipid metabolism and gut microbiota in HFD-fed mice when pork fat is half replaced with MLCT and palm stearin (PS). The results showed that although MLCT could increase the body weight in the mouse model, it can improve the energy utilization, regulate the glucose and lipid metabolism, and inhibit the occurrence of inflammation. Furthermore, 16S rRNA gene sequencing of gut microbiota indicated that PS and MLCT affected the overall structure of the gut microbiota to a varying extent and specifically changed the abundance of some operational taxonomic units (OTUs). Moreover, several OTUs belonging to the genera

Indexed as

Diet, High-FatGastrointestinal MicrobiomeAnimalsBody WeightGlycolipidsLipid MetabolismMiceMice, Inbred C57BLObesityRNA, Ribosomal, 16STriglyceridesGlycolipidsRNA, Ribosomal, 16STriglyceridesglucose homeostasisgut microbiotainflammationlipid metabolismMLCT

Identifiers

PMID36677779
PMCPMC9861698
OpenAlexW4315648030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.